p53 gene
Showing 1 - 25 of >10,000
p53 Gene in Metabolism Regulation in Li-Fraumeni Syndrome
Completed
- Mitochondrial Disorders
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 18, 2021
Metastatic Pancreatic Cancer Trial in Dallas (SGT-53, nab-paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Cancer
- SGT-53
- +2 more
-
Dallas, TexasMary Crowley Cancer Research Center
Feb 7, 2022
Ovarian Cancer, Peritoneal Cavity Cancer Trial in Dallas (Ad5CMV-p53 gene)
Completed
- Ovarian Cancer
- Peritoneal Cavity Cancer
- Ad5CMV-p53 gene
-
Dallas, TexasSimmons Cancer Center - Dallas
Jan 29, 2021
p53 and Response to Preoperative Radiotherapy for T2 and T3
Recruiting
- Rectal Cancer
- preoperative short course radiation
-
Vienna, AustriaMedical University of Vienna, Department of Surgery
Apr 6, 2022
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Lung Cancer Trial in Nashville, Green Bay (Ad5CMV-p53 gene)
Completed
- Lung Cancer
- Ad5CMV-p53 gene
-
Nashville, Tennessee
- +2 more
Oct 29, 2020
Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)
Recruiting
- Multiple Myeloma
- anti-BCMA CAR-T
- Selinexor-VRD
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023
Colorectal Cancer Metastatic, Colorectal Cancer Stage IV, TP53 Gene Mutation Trial in Bergen (Cyclophosphamide)
Terminated
- Colorectal Cancer Metastatic
- +2 more
-
Bergen, NorwayHaukeland University Hospital
Jan 20, 2021
SNPs in p53 and p53 Response Elements on Inflammatory Response
Completed
- HIV-1 Seropositive
- +3 more
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 21, 2023
Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)
Not yet recruiting
- Pediatric Cancer
- +2 more
- Arsenic trioxide
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023
Unusual Infiltrative Patterns of Malignant Cells in Endometrial
Not yet recruiting
- Endometrial Cancer
- (no location specified)
Mar 11, 2023
Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)
Not yet recruiting
- Relapsing-remitting Multiple Sclerosis
- CT-P53
- +2 more
- (no location specified)
Jun 7, 2023
Infiltrating Duct Carcinoma of the Breast
Not yet recruiting
- Invasive Breast Cancer
- (no location specified)
Jan 28, 2023
P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer
Completed
- Endometrial Cancer
- p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
-
Alexandria, EgyptHossam Hassan El Sokkary
Sep 13, 2022
Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)
Recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib plus RCHOP
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023
Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome Trial in Boston (Data and Specimen Collection)
Recruiting
- Li-Fraumeni Syndrome
- +4 more
- Data and Specimen Collection
-
Boston, Massachusetts
- +2 more
Jan 23, 2023
Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)
Not yet recruiting
- Endometrial Cancer
- Vaginal brachytherapy
- +2 more
- (no location specified)
Nov 29, 2022
Secondary Obliteration of Old Radical Cavities Using S53P4
Recruiting
- Mastoid Cavity
- S53P4 bioactive glass granules
-
Utrecht, NetherlandsDiakonessenhuis
Nov 1, 2023
Locally Advanced Cervical Cancer Trial in Mexico City (Curcumin, Curcumin + Piperine)
Recruiting
- Locally Advanced Cervical Cancer
- Curcumin
- Curcumin + Piperine
-
Mexico City, MexicoInstituto Nacional de Cancerología
Oct 6, 2023
DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)
Not yet recruiting
- DLBCL
- Selinexor combined with Prednisone, Etoposide, and Lenalidomide
-
Qingdao, Shandong, Chinathe affiliated hospital of Qingdao University
Aug 18, 2022
DLBCL Trial (Sintilimab, Rituximab)
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- (no location specified)
Mar 6, 2022
Follow-up Study on Female Carriers With DMD Gene Variants
Not yet recruiting
- Muscular Dystrophy
- +2 more
- No intervention
-
Copenhagen, DenmarkCopenhagen neuromuscular center
Feb 7, 2023
Vulvar Cancer Trial in Vancouver (Re-excision)
Not yet recruiting
- Vulvar Cancer
- Re-excision
-
Vancouver, British Columbia, CanadaBC Cancer - Vancouver Centre
Oct 8, 2022